Kim D, Durán W R, Kobayashi I, Daniels A J, Durán W N
Department of Physiology, UMDNJ-New Jersey Medical School, Newark 07103-2714.
Microvasc Res. 1994 Jul;48(1):124-34. doi: 10.1006/mvre.1994.1043.
We used the hamster cheek pouch microcirculation to investigate by intravital microscopy the effects of neuropeptide Y (NPY) on arteriolar diameter, leukocyte adhesion to microvascular endothelium, and postcapillary venular permeability. We applied NPY topically for 3 min at concentrations of 10(-7), 10(-9), and 10(-11) M. We quantified arteriolar diameter and permeability changes by digital image analysis. We used the mass of fluorescein isothiocyanate-Dextran 150 accumulated around postcapillary venules (10-30 microns) to calculate extravasation rates of macromolecules. We also measured the number of adhering white cells per 100-microns length of postcapillary venules using acridine orange to label white blood cells. At the applied doses, NPY did not alter either microvascular permeability to macromolecules or leukocyte adhesion to microvascular walls. NPY, in a dose-dependent manner, constricted arterioles ranging in control diameter from 10 to 60 microns. Vasoconstriction was strongest in arterioles ranging in diameter from 30 to 39 microns at a concentration of NPY of 10(-7) M. The Y1-type NPY receptor agonist, Leu31, Pro34-NPY, was as potent as NPY, whereas the carboxy-terminal fragment NPY 13-36 had no activity, indicating that the hamster cheek pouch microvasculature expresses the Y1 type of NPY receptor. We also blocked alpha-adrenergic receptors to test whether norepinephrine is required for NPY-induced vasoconstriction. This blockade did not inhibit the vasoconstriction caused by exogenous NPY. Our results demonstrate that (1) NPY modulates microvascular hemodynamics by changes in arteriolar diameter, (2) the NPY receptor on the hamster cheek pouch microvasculature is of the Y1 type, and (3) exogenous NPY-induced vasoconstriction is independent of the activity of endogenous norepinephrine.
我们利用仓鼠颊囊微循环,通过活体显微镜研究神经肽Y(NPY)对小动脉直径、白细胞与微血管内皮的黏附以及毛细血管后微静脉通透性的影响。我们以10(-7)、10(-9)和10(-11) M的浓度局部应用NPY 3分钟。我们通过数字图像分析对小动脉直径和通透性变化进行定量。我们利用在毛细血管后微静脉(10 - 30微米)周围积累的异硫氰酸荧光素 - 葡聚糖150的量来计算大分子的外渗率。我们还用吖啶橙标记白细胞,测量每100微米长度毛细血管后微静脉上黏附的白细胞数量。在所应用的剂量下,NPY既不改变微血管对大分子的通透性,也不改变白细胞与微血管壁的黏附。NPY以剂量依赖方式使直径在10至60微米的小动脉收缩。在NPY浓度为10(-7) M时,直径在30至39微米的小动脉收缩最强。Y1型NPY受体激动剂Leu31、Pro34 - NPY与NPY的作用效力相同,而羧基末端片段NPY 13 - 36无活性,这表明仓鼠颊囊微血管表达Y1型NPY受体。我们还阻断α - 肾上腺素能受体,以测试去甲肾上腺素是否是NPY诱导血管收缩所必需的。这种阻断并未抑制外源性NPY引起的血管收缩。我们的结果表明:(1)NPY通过改变小动脉直径来调节微血管血流动力学;(2)仓鼠颊囊微血管上的NPY受体是Y1型;(3)外源性NPY诱导的血管收缩独立于内源性去甲肾上腺素的活性。